Skip to main content
Skip to footer
Follow us on:
Podcast
Apple Podcast
Spotify
Amazon Music and Audible
About
Mission and Vision
ATRI Leadership
Timeline
Careers
Research
Clinical Trials
Sections
Studies
Site Locations
Participate
Basic Science
Education
Alzheimer’s Research Day San Diego
Student Summer Research Program
People
Our People
Leadership
Faculty & Team Leads
Teams
Resources
News & Events
Events Calendar
Resource Library
Donate Now
Study Tag:
Memory Impairement
Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS)
February 24, 2022
The LEADS study – or the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) explores the development of early-onset Alzheimer’s disease and…
Synaptic Therapy Alzheimer’s Research Trial
February 24, 2021
This study is investigating whether CT1812, a novel and promising therapeutic candidate can halt or slow the process of Alzheimer’s…
Life’s End Benefits of Cannabidiol and Tetrahydrocannabinol (LiBBY)
March 24, 2020
Approximately fifty percent of people diagnosed with Alzheimer’s disease or other types of dementia will receive hospice care at the…
Alzheimer’s Tau Platform (ATP) Study
March 22, 2020
Tau protein is an important target in Alzheimer’s disease (AD), and there is now strong evidence that tau in brain…
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
March 20, 2020
The Alzheimer’s Disease Neuroimaging Initiative (ADNI), a landmark study that began in 2004, is a public-private research partnership tasked with…
Memory Improvement Through Nicotine Dosing (MIND)
February 24, 2020
The purpose of the Memory Improvement Through Nicotine Dosing (MIND) study is to determine whether daily transdermal nicotine (patch) will…
SNIFF
February 24, 2019
The purpose of the SNIFF study is to find out whether a type of insulin, when administered as a nasal…
Connect
February 24, 2019
The Connect study tested whether an oral, experimental drug, AZD0530 (saracatinib), would slow progression in early stage Alzheimer’s disease (AD).…